U.S. Healthtech Stock News

Fresh commentary on Immatics (NasdaqCM:IMTX) highlights its evolution into a broader PRAME-focused oncology platform with multiple monetization paths, alongside reassurance that existing cash resources are expected to support operations into 2028. See our latest analysis for Immatics. Immatics shares recently traded at US$9.52, with a 1-day share price return of 4.73% and 7-day share price return of 7.33%. Over longer periods, the 30-day share price return is down 10.36% and the year-to-date...

VisionWave Holdings (VWAV) is in focus after using Eurosatory 2026 in Paris to publicly show its VARAN autonomous unmanned ground vehicle, STRATUM AI management platform, and SDNN AI architecture to the global defense community. See our latest analysis for VisionWave Holdings. Alongside the Eurosatory reveal and new data center joint venture term sheet, VisionWave Holdings has seen short term momentum pick up, with a 7 day share price return of 16.06% and a 30 day return of 9.47%. However,...

Recent defense milestones underscore Virtuix's expanding presence in AI-enabled military training and simulation.

The Fed’s latest meeting left rates steady at 3.5% to 3.75%, but a hint of a possible hike later this year, firmer inflation at 4.2%, and a push toward new data sources have quickly reshaped how investors think about risk and opportunity. For technology and data analytics stocks, the focus on real time information and alternative datasets could matter as much as the rate path itself. This article highlights 3 stocks from a US Technology and Data Analytics Providers screener that appear...

Bristol Myers Squibb (NYSE:BMY) reported positive late-stage clinical trial results for two multiple myeloma candidates. The company announced successful Phase III data for mezigdomide in combination with Kyprolis and dexamethasone. Early data for its CAR T-cell therapy arlocabtagene autoleucel showed a strong response rate with a manageable safety profile. The results were presented at the European Hematology Association Congress 2026. Bristol Myers Squibb is a global biopharmaceutical...

Coach, part of Tapestry (NYSE:TPR), has launched &Coach, a digital luxury content platform co-created with Gen Z. The platform focuses on social first storytelling and participatory campaigns, with younger creators embedded in the process. &Coach is intended to reshape how the Coach brand builds community and relevance with younger luxury consumers. Tapestry, trading at $145.87, sits behind Coach as its flagship brand and is leaning into a content driven approach to connect with younger...

Tariffs, shifting trade rules, and pressure on global supply chains are reshaping how investors think about US manufacturing stocks. Instead of relying on smooth cross-border trade, markets are reassessing companies that produce more at home and can better control their costs and inputs. This article looks at three US Domestic Manufacturing screener stocks that are directly exposed to these trade headlines and may react in different ways as policies evolve. Each stock is assessed on its...

With Kevin Warsh preparing for his first post-meeting press conference and the Federal Reserve keeping rates at 3.6% while inflation sits at 4.2%, many investors are rethinking how much risk they want to carry. Large-cap defensive stocks, often backed by steady dividends and stronger balance sheets, can look relatively appealing when rate cuts seem less likely and market swings pick up. This article highlights 3 stocks from our Large-Cap Defensive Stocks screener that appear positively...

With the Federal Reserve hinting at possible rate hikes in 2026 and inflation holding at 4.2%, value stocks are back in focus for investors who care about price tags as much as potential. Higher-for-longer rates can reward companies with resilient balance sheets and sensible valuations, while putting pressure on those priced for perfection. This article highlights three value stocks from our screener that are closely exposed to the latest Fed and inflation news. It explains why some investors...

John Wiley & Sons (WLY) closed FY 2026 with fourth quarter revenue of US$447.9 million and basic EPS of US$2.65, supported by trailing twelve month EPS of US$4.22 on revenue of US$1.68 billion. Over recent periods, the company has seen quarterly revenue move from US$404.6 million in FY 2025 Q3 to US$442.6 million in FY 2025 Q4 and then to US$447.9 million in FY 2026 Q4. Basic EPS shifted from a loss of US$0.43 in FY 2025 Q3 to US$1.27 in FY 2025 Q4 and US$2.65 in FY 2026 Q4, alongside...

Earlier in 2026, CorMedix Inc. reported strong Q1 results driven by DefenCath and raised its full-year 2026 guidance while outlining progress on late-stage programs such as REZZAYO. Management also emphasized continued business momentum even as the company prepares for the expiration of temporary TDAPA reimbursement, highlighting execution in a changing reimbursement backdrop. Next, we will examine how CorMedix's raised 2026 guidance and DefenCath’s contribution shape the company’s broader...

Allison Transmission Holdings (NYSE:ALSN) secured a record US$250 million contract to supply its advanced 4040 MX transmissions for BAE Systems’ CV90 MkIV tracked defense vehicles. The agreement is described as the largest tracked defense program deal in Allison Transmission’s history. The 4040 MX transmission will move from development into a full production platform under this contract, with deliveries scheduled to begin in 2028 after integration testing with BAE. For investors following...

10x Genomics (NasdaqGS:TXG) announced a multi-year research collaboration with Cleveland Clinic focused on bladder cancer diagnostics. The partnership centers on using single-cell, spatial transcriptomic, and protein profiling technologies to build multimodal cancer datasets. The collaborators plan to link molecular data with clinical outcomes, aiming to support future diagnostic applications across oncology. 10x Genomics enters this Cleveland Clinic collaboration with its stock at $31.75...

Citizens Financial Group (NYSE:CFG) has appointed Chris Emerson as Head of Investor Relations, while he continues to lead Corporate Planning and Enterprise Finance. Kristin Silberberg is moving into the role of Chief Financial Officer of the Commercial Bank. These leadership changes place new executives in key financial and investor-facing positions at the company. Citizens Financial Group enters these leadership shifts with NYSE:CFG trading at $67.27. Over the past year, the stock is up...

If you are wondering whether Park Hotels & Resorts stock still offers value at around US$14.69, the key question is how its current price compares with what the business might reasonably be worth. The stock has returned 3.8% over the past week, 36.5% over the last month, 36.4% year to date, 58.3% over the last year, 64.2% over three years and 0.1% over five years, which can change how investors think about both upside potential and risk. Recent news coverage around Park Hotels & Resorts has...

The United States market has experienced a 2.3% increase over the last week and a significant 25% rise in the past year, with earnings projected to grow by 19% annually. In such an environment, identifying stocks that may be priced below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervaluation amidst robust market growth.

Over the last 7 days, the United States market has risen by 2.3%, contributing to a robust 25% increase over the past year, with earnings forecasted to grow by 19% annually. In this thriving environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those closest to the business in its potential for future success.

US manufacturing stocks are back in focus as fresh tariff proposals, trade investigations, and the prospect of a new US-China Board of Trade reshape expectations for supply chains and costs. For investors, the question is which US Domestic Manufacturing Stocks could potentially benefit from this policy turn and which might face pressure as trade relationships evolve. This article highlights 3 stocks from the screener that are directly exposed to these trade headlines, explaining how the same...

In the past week, EZCORP drew higher trading interest as investors reacted to expectations for upcoming quarterly earnings of US$0.39 per share and projected revenue of US$405 million, both seen higher than the prior year. This shift in sentiment highlights how earnings and revenue forecasts can quickly reshape perceptions of EZCORP’s operating momentum and business trajectory. We’ll now examine how these stronger earnings and revenue expectations could influence EZCORP’s investment...

Some Madison Square Garden Entertainment Corp. ( NYSE:MSGE ) shareholders may be a little concerned to see that the...

When companies post strong earnings, the stock generally performs well, just like Victoria's Secret & Co.'s ( NYSE:VSXY...

We'd be surprised if Kontoor Brands, Inc. ( NYSE:KTB ) shareholders haven't noticed that the Executive VP, Jennifer...

We'd be surprised if Viant Technology Inc. ( NASDAQ:DSP ) shareholders haven't noticed that the Chief Financial...

G-III Apparel Group, Ltd.'s ( NASDAQ:GIII ) recent soft profit numbers didn't appear to worry shareholders, as the...